1. Home
  2. CHRO vs ASTI Comparison

CHRO vs ASTI Comparison

Compare CHRO & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • ASTI
  • Stock Information
  • Founded
  • CHRO 2002
  • ASTI 2005
  • Country
  • CHRO United States
  • ASTI United States
  • Employees
  • CHRO N/A
  • ASTI N/A
  • Industry
  • CHRO
  • ASTI Semiconductors
  • Sector
  • CHRO
  • ASTI Technology
  • Exchange
  • CHRO Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • CHRO 3.8M
  • ASTI 4.3M
  • IPO Year
  • CHRO 2024
  • ASTI N/A
  • Fundamental
  • Price
  • CHRO $1.90
  • ASTI $2.65
  • Analyst Decision
  • CHRO Strong Buy
  • ASTI
  • Analyst Count
  • CHRO 1
  • ASTI 0
  • Target Price
  • CHRO N/A
  • ASTI N/A
  • AVG Volume (30 Days)
  • CHRO 855.2K
  • ASTI 120.4K
  • Earning Date
  • CHRO 02-20-2025
  • ASTI 02-19-2025
  • Dividend Yield
  • CHRO N/A
  • ASTI N/A
  • EPS Growth
  • CHRO N/A
  • ASTI N/A
  • EPS
  • CHRO N/A
  • ASTI N/A
  • Revenue
  • CHRO N/A
  • ASTI $44,673.00
  • Revenue This Year
  • CHRO N/A
  • ASTI N/A
  • Revenue Next Year
  • CHRO N/A
  • ASTI N/A
  • P/E Ratio
  • CHRO N/A
  • ASTI N/A
  • Revenue Growth
  • CHRO N/A
  • ASTI N/A
  • 52 Week Low
  • CHRO $0.45
  • ASTI $2.25
  • 52 Week High
  • CHRO $6.00
  • ASTI $87.80
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 86.63
  • ASTI 47.29
  • Support Level
  • CHRO $0.81
  • ASTI $2.49
  • Resistance Level
  • CHRO $1.10
  • ASTI $2.78
  • Average True Range (ATR)
  • CHRO 0.26
  • ASTI 0.40
  • MACD
  • CHRO 0.08
  • ASTI -0.05
  • Stochastic Oscillator
  • CHRO 70.64
  • ASTI 10.20

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: